CN110672840A - Sandwich method antibody detection method and test paper - Google Patents

Sandwich method antibody detection method and test paper Download PDF

Info

Publication number
CN110672840A
CN110672840A CN201910921771.7A CN201910921771A CN110672840A CN 110672840 A CN110672840 A CN 110672840A CN 201910921771 A CN201910921771 A CN 201910921771A CN 110672840 A CN110672840 A CN 110672840A
Authority
CN
China
Prior art keywords
solution
raw material
antigen
mixed solution
fluorescent raw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910921771.7A
Other languages
Chinese (zh)
Inventor
宋禹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koch Biological Technology (beijing) Co Ltd
Original Assignee
Koch Biological Technology (beijing) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koch Biological Technology (beijing) Co Ltd filed Critical Koch Biological Technology (beijing) Co Ltd
Priority to CN201910921771.7A priority Critical patent/CN110672840A/en
Publication of CN110672840A publication Critical patent/CN110672840A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The invention discloses a sandwich method antibody detection method and test paper. Wherein, the method comprises the following steps: dissolving a first reagent into an ethanol solution to prepare a first solution; and dissolving the second reagent into the ethanol solution to prepare a second solution; mixing the first solution, the second solution and the fluorescent raw material solution to obtain a first mixed solution; removing supernatant in the first mixed solution, and performing ultrasonic dispersion treatment on the first mixed solution by using ultrasonic waves to obtain activated fluorescent raw material liquid; labeling a detection antigen by using an activated fluorescent raw material solution; preparing a coating antigen according to the marked detection antigen; combining a sample to be detected with a detection antigen and a coating antigen; collecting the intensity of the fluorescence signal emitted by the detection antigen. The invention solves the technical problems that the step of activating the fluorescent raw material is usually to adopt a solution test tube or a beaker to shake up manually, the shaking up effect is usually poor, the mixing is not uniform enough, microspheres after crosslinking antibodies are agglomerated, and the running of the microspheres becomes poor.

Description

Sandwich method antibody detection method and test paper
Technical Field
The invention relates to the field of biological detection, in particular to a sandwich method antibody detection method and test paper.
Background
With the continuous development of novel experimental means, an ultrasonic device is utilized to treat the solution in the field of biological detection, and the original step of manual uniform mixing is replaced. At present, technicians in the field of biological detection often utilize a double-antigen sandwich method for detection when performing antigen detection, the double-antigen sandwich method for antibody detection has the advantages of high accuracy, convenient operation and the like, and is favored by technicians in the field of biological detection.
In view of the above problems, no effective solution has been proposed.
Disclosure of Invention
The embodiment of the invention provides a sandwich method antibody detection method and test paper, which at least solve the technical problems that in the step of activating a fluorescent raw material, a solution test tube or a beaker is often manually operated to shake up, the shaking up effect is often poor, the mixing is not uniform enough, microspheres after antibody crosslinking are aggregated, and the running strip of the microspheres is poor.
According to an aspect of an embodiment of the present invention, there is provided a sandwich method antibody detection method, including: dissolving a first reagent into an ethanol solution to prepare a first solution; and dissolving the second reagent into the ethanol solution to prepare a second solution; mixing the first solution, the second solution and the fluorescent raw material solution to obtain a first mixed solution; removing supernatant in the first mixed solution, and performing ultrasonic dispersion treatment on the first mixed solution by using ultrasonic waves to obtain activated fluorescent raw material liquid; labeling a detection antigen by using an activated fluorescent raw material solution; preparing a coating antigen according to the marked detection antigen; combining a sample to be detected with a detection antigen and a coating antigen; collecting the intensity of the fluorescence signal emitted by the detection antigen.
Optionally, before preparing the first solution by dissolving the first reagent into the ethanol solution, the method further comprises: carrying out ultrasonic dispersion on the fluorescent raw material; ultrapure water is added to the dispersed fluorescent raw material to dilute the fluorescent raw material, thereby obtaining a fluorescent raw material liquid.
Optionally, before removing the supernatant in the first mixed solution and performing ultrasonic dispersion treatment on the first mixed solution by using ultrasonic waves to obtain an activated fluorescent raw material solution, the method further includes: carrying out ultrasonic treatment on the first mixed solution; and centrifuging the first mixed solution after ultrasonic treatment.
Optionally, mixing the first solution, the second solution, and the fluorescent raw material solution to obtain a first mixed solution includes: adding the first solution into a fluorescent raw material solution, and fully mixing the first solution and the fluorescent raw material solution until the first solution and the fluorescent raw material solution are uniform to obtain a second mixed solution; adding the second solution into the second mixed solution, and fully mixing the solution until the solution is uniform to obtain a third mixed solution; and standing the third mixed solution at normal temperature for a first preset time to obtain a first mixed solution.
Optionally, removing a supernatant in the first mixed solution, and performing ultrasonic dispersion treatment on the first mixed solution by using ultrasonic waves to obtain an activated fluorescent raw material solution includes: pouring out the supernatant in the first mixed solution to obtain a fourth mixed solution; adding ultrapure water into the fourth mixed solution to obtain a fifth mixed solution; and carrying out ultrasonic treatment on the fifth mixed solution to obtain activated fluorescent raw material solution.
Optionally, labeling the detection antigen with an activated fluorescent stock solution comprises: adding a detection antigen into an activated fluorescent raw material solution; and adding bovine serum albumin into the activated fluorescent raw material solution to obtain the detection antigen marked by the activated fluorescent raw material solution.
Optionally, after adding the detection antigen to the activated fluorescent feedstock solution, the method further comprises: standing the activated fluorescent raw material liquid added with the detection antigen for a second preset time; and ultrasonically treating the activated fluorescent raw material liquid which is static for a second preset time by using ultrasonic waves, and continuously standing for a third preset time after the ultrasonic treatment.
Optionally, adding bovine serum albumin into the activated fluorescent raw material solution to obtain the detection antigen labeled by the activated fluorescent raw material solution includes: adding bovine serum albumin into the activated fluorescent raw material solution added with the detection antigen, and sealing for a fourth preset time; carrying out centrifugal treatment on the activated fluorescent raw material liquid after the fourth preset time is closed; and adding a preservation solution into the activated fluorescent raw material solution after centrifugation.
Optionally, preparing the coating antigen based on the labeled detection antigen comprises: preparing a coating solution by using an antigen for detecting the antigen; and preparing a coating pad according to the coating solution to form the solid-phase coating antigen.
Optionally, the fluorescence signal intensity is linearly proportional to the amount of antigen in the sample to be tested.
According to another aspect of the embodiment of the invention, the sandwich method antibody detection test paper is further provided, and is manufactured according to the sandwich method antibody detection method, and is used for detecting the quantity of the antigen in the sample to be detected.
In the embodiment of the invention, the purpose of uniformly dispersing the activated fluorescent raw material liquid is achieved by adopting a mode of preparing an activated fluorescent marker to mark a detection antigen and utilizing a coating antigen and the detection antigen to be combined with an antibody to be detected for detection through ultrasonic treatment, so that the technical effects that microspheres after the antibody is crosslinked are not agglomerated and the running strips of the microspheres are not deteriorated are realized, and the technical problems that the steps of activating the fluorescent raw material are often performed by manually operating a solution test tube or a beaker for even shaking, the even shaking effect is often poor, the mixing is not uniform and sufficient, the microspheres after the antibody is crosslinked are agglomerated and the running strips of the microspheres are poor are solved.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this application, illustrate embodiment(s) of the invention and together with the description serve to explain the invention without limiting the invention. In the drawings:
FIG. 1 is a flow chart of a sandwich method antibody detection method according to an embodiment of the present invention.
Detailed Description
In order to make the technical solutions of the present invention better understood, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
It should be noted that the terms "first," "second," and the like in the description and claims of the present invention and in the drawings described above are used for distinguishing between similar elements and not necessarily for describing a particular sequential or chronological order. It is to be understood that the data so used is interchangeable under appropriate circumstances such that the embodiments of the invention described herein are capable of operation in sequences other than those illustrated or described herein. Furthermore, the terms "comprises," "comprising," and "having," and any variations thereof, are intended to cover a non-exclusive inclusion, such that a process, method, system, article, or apparatus that comprises a list of steps or elements is not necessarily limited to those steps or elements expressly listed, but may include other steps or elements not expressly listed or inherent to such process, method, article, or apparatus.
In accordance with an embodiment of the present invention, there is provided an embodiment of a sandwich method antibody detection method, it is noted that the steps illustrated in the flowchart of the drawings may be performed in a computer system such as a set of computer executable instructions, and that while a logical order is illustrated in the flowchart, in some cases the steps illustrated or described may be performed in an order different than here.
Fig. 1 is a method for detecting an antibody by a sandwich method according to an embodiment of the present invention, as shown in fig. 1, the method including the steps of:
step S102, a first reagent is dissolved in an ethanol solution to prepare a first solution.
Specifically, the first reagent may be N-hydroxysuccinimide (NHS) having a strong oxidative tracer property, and the use of the first reagent is suitable for preparing a mixed functional solution of a plurality of reagents because of its high reaction stability and high speed, and thus the first solution can be prepared by mixing the reagent with a dissolution-dedicated reagent. For example, 50mg of N-hydroxysuccinimide (NHS) can be weighed out and dissolved in ethanol to prepare a solution having a concentration of 50 mg/ml.
The solvent for dissolving the first reagent may be ethanol or other hydrophilic inorganic solvent, and is not particularly limited since it mainly functions to dissolve and disperse the reagent.
Optionally, before preparing the first solution by dissolving the first reagent into the ethanol solution, the method further comprises: carrying out ultrasonic dispersion on the fluorescent raw material; ultrapure water is added to the dispersed fluorescent raw material to dilute the fluorescent raw material, thereby obtaining a fluorescent raw material liquid.
Specifically, before the first reagent is dissolved in the ethanol solution to prepare the first solution, the purchased fluorescent raw material needs to be processed, the fluorescent raw material can be fluorescent latex microspheres, and after the fluorescent latex microspheres are subjected to ultrasonic processing by an ultrasonic device, the fluorescent latex microspheres can generate a scattering effect, namely, the fluorescent latex microspheres are dispersed at the edge of the container in a discrete state, and then a certain amount of ultrapure water is added into the container for dilution and uniformly stirred to obtain the fluorescent raw material solution. For example, the purchased fluorescent latex microspheres are ultrasonically dispersed by an ultrasonic cleaner and shaken up by combining with manual measures of operators, wherein the time for ultrasonic dispersion is about 1min, 100ul of fluorescent latex microsphere suspension with the solid content of 1% is taken and diluted by 10 times with ultrapure water, namely the diluted volume is 1000ul, and the diluted fluorescent latex microsphere suspension is added into a test tube for subsequent treatment.
It should be noted that the fluorescent latex microspheres are preferred fluorescent raw materials for immunochromatography, and are selected as fluorescent raw materials in the embodiments of the present invention due to the characteristics of low price, low requirement for fluorescent reaction environment, high fluorescence intensity, and the like. In addition, the embodiment of the present invention uses ultrapure water for dilution, and since ultrapure water (uidpure water) is also called UP water, it refers to water having a resistivity of 18M Ω × cm (25 ℃). The water has few impurities except water molecules, no organic matters such as bacteria, viruses and chlorine-containing dioxin, and certainly no mineral trace elements required by human bodies, namely water with all atoms except oxygen and hydrogen removed. Can be used for the preparation process of ultrapure materials (semiconductor element materials, nano fine ceramic materials and the like) by applying distillation, deionization, reverse osmosis technology or other appropriate supercritical fine technology.
Step S104, dissolving the second reagent in the ethanol solution to prepare a second solution.
Specifically, the second reagent can be selected from 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC) with strong reduction tracing property, and the application of the second reagent has high reaction stability and high speed, and is suitable for preparing a mixed functional solution of multiple reagents, so that the second solution can be prepared after the reagent is mixed with a special dissolving reagent. For example, 50mg of 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC) can be weighed out and dissolved in ethanol to prepare a solution having a concentration of 50 mg/ml.
The solvent for dissolving the second reagent may be ethanol or other hydrophilic inorganic solvent, and is not particularly limited since it mainly functions to dissolve and disperse the reagent.
And step S106, mixing the first solution, the second solution and the fluorescent raw material solution to obtain a first mixed solution.
Specifically, the first solution, the second solution and the fluorescent raw material solution obtained in the above-described embodiment of the present invention were mixed in the same container, respectively, to obtain a first mixed solution, i.e., a mixed solution containing three kinds of mixed reagent components.
Optionally, mixing the first solution, the second solution, and the fluorescent raw material solution to obtain a first mixed solution includes: adding the first solution into a fluorescent raw material solution, and fully mixing the first solution and the fluorescent raw material solution until the first solution and the fluorescent raw material solution are uniform to obtain a second mixed solution; adding the second solution into the second mixed solution, and fully mixing the solution until the solution is uniform to obtain a third mixed solution; and standing the third mixed solution at normal temperature for a first preset time to obtain a first mixed solution.
Specifically, 40ul of the first solution is taken from the first solution beaker, and added into the fluorescent raw material solution obtained in the above embodiment to be uniformly mixed, so as to obtain a second mixed solution (formed by mixing the first solution and the fluorescent raw material solution), wherein the uniformly mixing may be performed by using a method of manual stirring by an operator to stir the beaker clockwise. Then, 40ul of the second solution was taken out of the second solution beaker, added to the second mixed solution by a dropper, and mixed uniformly to obtain a third mixed solution (formed by mixing the first solution, the second solution, and the fluorescent raw material solution), and finally the tube was reacted at room temperature for 0.5 hour to obtain the first mixed solution.
In the above embodiment, the first preset time for standing is determined according to the ambient temperature and the fluorescent raw material, and when the fluorescent raw material is the fluorescent latex microspheres and the ambient temperature is normal temperature (room temperature), the first preset time may be 0.5 hour.
And S108, removing the supernatant in the first mixed solution, and performing ultrasonic dispersion treatment on the first mixed solution by using ultrasonic waves to obtain an activated fluorescent raw material solution.
Optionally, removing a supernatant in the first mixed solution, and performing ultrasonic dispersion treatment on the first mixed solution by using ultrasonic waves to obtain an activated fluorescent raw material solution includes: pouring out the supernatant in the first mixed solution to obtain a fourth mixed solution; adding ultrapure water into the fourth mixed solution to obtain a fifth mixed solution; and carrying out ultrasonic treatment on the fifth mixed solution to obtain activated fluorescent raw material solution.
Specifically, the mixed solution may have a supernatant part due to the mixing of different reagents, wherein the supernatant part refers to a clear and transparent liquid with a lower density at the upper layer caused by the chromatography of the mixed substance at the upper layer and the lower layer of the mixed solution. After the supernatant in the first mixed solution is poured off, the obtained solution is a fourth mixed solution, so that the fourth mixed solution is a part of the first mixed solution, ultrapure water is added into the fourth mixed solution to perform a dilution operation to obtain a fifth mixed solution, and finally the fifth mixed solution is subjected to ultrasonic treatment of ultrasonic waves to obtain an activated fluorescent raw material solution.
For example, after the first mixed solution is obtained, an operator pours the solution supernatant in a test tube or a beaker, and adds 1ml of ultrapure water for dilution, and after the first mixed solution is uniformly stirred by hand, the first mixed solution is uniformly dispersed by ultrasonic wave, and the first mixed solution is ultrasonically mixed by an ultrasonic device, so that the uniformity of the activated fluorescent raw material solution can be greatly improved, the preparation precision of the activated fluorescent raw material solution is improved, and the technical problem that microspheres after cross-linking antibodies are agglomerated only by manual mixing, and the running bands of the microspheres are poor is solved.
Optionally, before removing the supernatant in the first mixed solution and performing ultrasonic dispersion treatment on the first mixed solution by using ultrasonic waves to obtain an activated fluorescent raw material solution, the method further includes: carrying out ultrasonic treatment on the first mixed solution; and centrifuging the first mixed solution after ultrasonic treatment.
Specifically, the ultrasonic dispersion treatment of the ultrasonic device on the first mixed solution contributes to uniform mixing of the first mixed solution, and the purpose of centrifuging the first mixed solution after the ultrasonic treatment is to precipitate the supernatant of the first mixed solution by utilizing a chromatography layer, so that the supernatant can be poured off in the subsequent treatment, and the concentrated mixed substance is retained.
For example, the first mixed solution after 0.5 hour standing reaction is subjected to ultrasonic treatment by an ultrasonic device to re-suspend the fluorescent latex microspheres on the tube wall in the aqueous solution, and then the first mixed solution is subjected to centrifugation, wherein the centrifugation conditions can be 10000r/min and the centrifugation lasts for 20 min.
Step S110, labeling the detection antigen with the activated fluorescent raw material solution.
Specifically, the activated fluorescent raw material solution is used for labeling an antibody of a detection antigen, after the detection antigen is labeled, namely the activated fluorescent raw material solution can be attached to the detection antigen and is stably connected through a chemical bond, and when the surrounding detection environment stimulates the activated fluorescent material to perform a fluorescent reaction, the fluorescent reaction can be used as a characterization phenomenon of the detection antigen for measurement and analysis.
Optionally, labeling the detection antigen with an activated fluorescent stock solution comprises: adding a detection antigen into an activated fluorescent raw material solution; and adding bovine serum albumin into the activated fluorescent raw material solution to obtain the detection antigen marked by the activated fluorescent raw material solution.
Specifically, since the embodiment of the present invention requires that the detected object is an antigen, a corresponding antibody is also required as a detection tool, and the presence of the antigen can be detected after the antigen is bound to the antibody. After the detection antigen is mixed with the activated fluorescent raw material liquid, Bovine Serum Albumin (BSA) is required to be added as a carrier, the BSA is added to enable the detection antigen and the activated fluorescent raw material liquid to form a polymerase chain relationship, and the detection antigen can have a fluorescent reaction function due to the stable relationship.
Bovine serum albumin is a simple protein in bovine serum, is a main component of blood (38g/100ml), and has a molecular weight of 68 kD. Isoelectric point 4.8. Nitrogen content 16%, sugar content 0.08%. Only contains hexose and hexylamine, and the fat content is only 0.2%. Albumin consists of 581 amino acid residues, of which 35 cysteines constitute 17 disulfide bonds, with a free thiol group at position 34 of the peptide chain. Albumin can bind to a variety of cations, anions, and other small molecule species. The albumin in the blood mainly plays a role in maintaining osmotic pressure, PH buffering, carrier and nutrition. During the serum-free culture of animal cells, albumin is added to play a role in physiological and mechanical protection and a role in a carrier. Bovine Serum Albumin (BSA), also known as the fifth component, is a globulin in bovine serum, containing 583 amino acid residues, having a molecular weight of 66.430kDa and an isoelectric point of 4.7.
Optionally, adding bovine serum albumin into the activated fluorescent raw material solution to obtain the detection antigen labeled by the activated fluorescent raw material solution includes: adding bovine serum albumin into the activated fluorescent raw material solution added with the detection antigen, and sealing for a fourth preset time; carrying out centrifugal treatment on the activated fluorescent raw material liquid after the fourth preset time is closed; and adding a preservation solution into the activated fluorescent raw material solution after centrifugation.
Optionally, after adding the detection antigen to the activated fluorescent feedstock solution, the method further comprises: standing the activated fluorescent raw material liquid added with the detection antigen for a second preset time; and ultrasonically treating the activated fluorescent raw material liquid which is static for a second preset time by using ultrasonic waves, and continuously standing for a third preset time after the ultrasonic treatment.
Specifically, for example, 1ml of the activated fluorescence raw material solution is taken and ultrasonically dispersed to be uniform, and then the detection antigen is dropped while stirring, and the amount of the detection antigen to be dropped may be 0.01mg to 0.05mg/ml, and further, the optimum amount of the dropping is generally 0.02 mg/ml. Wherein, the detection antigen can be anti-human lgG antigen, the process is about standing reaction for 1-2min, then ultrasonic treatment is carried out on an ultrasonic device for about 30 seconds, and then standing reaction is carried out for 1 hour again. BSA (final concentration at 0.50%) was then added to the reaction beaker for blocking for 1-2 hours (fourth preset time). Wherein, blocking refers to self-carrying out an independent reaction isolated from contact with environmental factors. And finally, centrifuging the sealed microspheres at the speed of 10000r/min for 15min, adding the preservation solution into the detection antigen marked by the activated fluorescent raw material solution to uniformly disperse the microspheres, and preserving for a long time.
In step S112, a coating antigen is prepared based on the labeled detection antigen.
Optionally, preparing the coating antigen based on the labeled detection antigen comprises: preparing a coating solution by using an antigen for detecting the antigen; and preparing a coating pad according to the coating solution to form the solid-phase coating antigen.
Specifically, the coating solution and the coating pad are two substances required by coating antigen solid phase, wherein the coating solution is prepared by using antigen for detecting the antigen, for example, aspergillus galactomannan antigen for coating is firstly taken and added into phosphate buffer solution to prepare the coating solution for detecting the line; adding goat anti-mouse IgG into phosphate buffer solution to prepare quality control line coating solution. The coating liquid comprises the following components: 0.01-0.05 phosphate buffer, having a pH of between 6.5 and 8.5.
It should be noted that the coating solution detection line and the quality control line are both methods for determining whether the immobilized phase of the coating antigen meets the standard, and since the manufacturing of the coating solution and the coating pad is the key for matching the coating antigen and the detection antigen to detect the antigen, the preparation of the coating solution in the above embodiment needs to manufacture the detection line and the quality control line according to different IgG or antigens.
Step S114, combining the sample to be detected with the detection antigen and the coating antigen.
Specifically, the sample to be detected contains an antigen to be detected, when the sample to be detected is mixed with the detection antigen and the envelope antigen, the mixing can be dropwise mixing or ultrasonic stirring mixing, the detection antigen and the envelope antigen sandwich the sample to be detected to form a sandwich state, which is also called double-antibody sandwich method detection antigen.
Step S116, collecting the intensity of the fluorescence signal emitted by the detection antigen.
Specifically, because the detection antigen and the activated fluorescent material are labeled, when the antigen in the sample to be detected is combined with the detection antigen, the fluorescence emitted by the detection antigen represents the quantity or distribution of the detection antigen, and therefore the quantity or distribution of the antibody to be detected, so that the purpose of detecting the antibody to be detected through the detection antigen is achieved.
It should be noted that, the fluorescence signal intensity can be collected by a fluorescence intensity collector, which is based on the detection principle of tracing fluorescence wavelength, and can precisely collect and analyze the tiny fluorescence label in the detection antigen, so as to accurately calculate the data of the antibody to be detected.
Optionally, the fluorescence signal intensity is linearly proportional to the amount of antigen in the sample to be tested.
Through the steps, the technical effects that the microspheres after the antibodies are crosslinked are not agglomerated and the running strips of the microspheres are not deteriorated can be realized.
According to another aspect of the embodiment of the invention, the sandwich method antibody detection test paper is further provided, and is manufactured according to the sandwich method antibody detection method, and is used for detecting the quantity of the antigen in the sample to be detected. For example, the manufacturing process steps of the test paper can be as follows: dissolving a first reagent into an ethanol solution to prepare a first solution; and dissolving the second reagent into the ethanol solution to prepare a second solution; mixing the first solution, the second solution and the fluorescent raw material solution to obtain a first mixed solution; removing supernatant in the first mixed solution, and performing ultrasonic dispersion treatment on the first mixed solution by using ultrasonic waves to obtain activated fluorescent raw material liquid; labeling a detection antigen by using an activated fluorescent raw material solution; preparing a coating antigen according to the marked detection antigen; combining a sample to be detected with a detection antigen and a coating antigen; collecting the intensity of the fluorescence signal emitted by the detection antigen.
Specifically, the above description of the embodiments of the present invention describes only the steps of manufacturing a sandwich-type antibody test strip, for example, a step of manufacturing a final antibody test reagent of the test strip when preparing a first solution by dissolving the first reagent in an ethanol solution, and a step of binding a sample to be tested to a test antigen and a coating antigen, i.e., applying the test strip manufactured according to the previous steps (i.e., a test strip containing the test antigen and the coating antigen).
The above-mentioned serial numbers of the embodiments of the present invention are merely for description and do not represent the merits of the embodiments.
In the above embodiments of the present invention, the descriptions of the respective embodiments have respective emphasis, and for parts that are not described in detail in a certain embodiment, reference may be made to related descriptions of other embodiments.
In the embodiments provided in the present application, it should be understood that the disclosed technology can be implemented in other ways. The above-described embodiments of the apparatus are merely illustrative, and for example, the division of the units may be a logical division, and in actual implementation, there may be another division, for example, multiple units or components may be combined or integrated into another system, or some features may be omitted, or not executed. In addition, the shown or discussed mutual coupling or direct coupling or communication connection may be an indirect coupling or communication connection through some interfaces, units or modules, and may be in an electrical or other form.
The units described as separate parts may or may not be physically separate, and parts displayed as units may or may not be physical units, may be located in one place, or may be distributed on a plurality of units. Some or all of the units can be selected according to actual needs to achieve the purpose of the solution of the embodiment.
In addition, functional units in the embodiments of the present invention may be integrated into one processing unit, or each unit may exist alone physically, or two or more units are integrated into one unit. The integrated unit can be realized in a form of hardware, and can also be realized in a form of a software functional unit.
The integrated unit, if implemented in the form of a software functional unit and sold or used as a stand-alone product, may be stored in a computer readable storage medium. Based on such understanding, the technical solution of the present invention may be embodied in the form of a software product, which is stored in a storage medium and includes instructions for causing a computer device (which may be a personal computer, a server, or a network device) to execute all or part of the steps of the method according to the embodiments of the present invention. And the aforementioned storage medium includes: a U-disk, a Read-Only Memory (ROM), a Random Access Memory (RAM), a removable hard disk, a magnetic or optical disk, and other various media capable of storing program codes.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.

Claims (11)

1. A sandwich method antibody detection method is characterized by comprising the following steps:
dissolving a first reagent into an ethanol solution to prepare a first solution; and
dissolving a second reagent into the ethanol solution to prepare a second solution;
mixing the first solution, the second solution and a fluorescent raw material solution to obtain a first mixed solution;
removing the supernatant in the first mixed solution, and performing ultrasonic dispersion treatment on the first mixed solution by using ultrasonic waves to obtain an activated fluorescent raw material solution;
labeling a detection antigen with the activated fluorescent raw material solution;
preparing a coating antigen according to the marked detection antigen;
combining a sample to be tested with the detection antigen and the coating antigen;
collecting the intensity of the fluorescence signal emitted by the detection antigen.
2. The method of claim 1, wherein prior to preparing the first solution by dissolving the first reagent into the ethanol solution, the method further comprises:
carrying out ultrasonic dispersion on the fluorescent raw material;
and adding ultrapure water into the dispersed fluorescent raw material for dilution to obtain the fluorescent raw material liquid.
3. The method according to claim 1, wherein before removing the supernatant from the first mixed solution and subjecting the first mixed solution to ultrasonic dispersion treatment using ultrasonic waves to obtain an activated fluorescent raw material solution, the method further comprises:
carrying out ultrasonic treatment on the first mixed solution;
and centrifuging the first mixed solution after ultrasonic treatment.
4. The method of claim 1, wherein mixing the first solution, the second solution, and the fluorescent feedstock solution to obtain a first mixed solution comprises:
adding the first solution into the fluorescent raw material solution, and fully mixing the first solution and the fluorescent raw material solution until the first solution and the fluorescent raw material solution are uniform to obtain a second mixed solution;
adding the second solution into the second mixed solution, and fully mixing the solution and the second mixed solution until the solution is uniform to obtain a third mixed solution;
and standing the third mixed solution at normal temperature for a first preset time to obtain the first mixed solution.
5. The method of claim 1, wherein removing the supernatant from the first mixed solution and subjecting the first mixed solution to ultrasonic dispersion treatment using ultrasonic waves to obtain an activated fluorescent raw material solution comprises:
pouring out the supernatant in the first mixed solution to obtain a fourth mixed solution;
adding ultrapure water into the fourth mixed solution to obtain a fifth mixed solution;
and carrying out ultrasonic treatment on the fifth mixed solution to obtain the activated fluorescent raw material solution.
6. The method of claim 1, wherein labeling a detection antigen with the activated fluorescent feedstock solution comprises:
adding the detection antigen to the activated fluorescent raw material solution;
and adding bovine serum albumin into the activated fluorescent raw material liquid to obtain the detection antigen marked by the activated fluorescent raw material liquid.
7. The method of claim 6, wherein after adding the detection antigen to the activated fluorescent feedstock solution, the method further comprises:
standing the activated fluorescent raw material liquid added with the detection antigen for a second preset time;
and ultrasonically treating the activated fluorescent raw material liquid which is static for a second preset time by using ultrasonic waves, and continuously standing for a third preset time after the ultrasonic treatment.
8. The method of claim 6, wherein adding bovine serum albumin to the activated fluorescent feedstock to obtain the detection antigen labeled with the activated fluorescent feedstock comprises:
adding bovine serum albumin into the activated fluorescent raw material solution added with the detection antigen, and sealing for a fourth preset time;
carrying out centrifugal treatment on the activated fluorescent raw material liquid after the fourth preset time is closed;
and adding a preservation solution into the activated fluorescent raw material solution after centrifugation.
9. The method of claim 1, wherein preparing the coating antigen based on the labeled test antigen comprises:
preparing a coating solution by using the antigen for detecting the antigen;
and manufacturing a coating pad according to the coating solution to form the solid-phase coating antigen.
10. The method of claim 1, wherein the fluorescence signal intensity is linearly proportional to the amount of antigen in the test sample.
11. A sandwich antibody test strip, produced according to any one of claims 1 to 10, for detecting the amount of an antibody in a sample to be tested.
CN201910921771.7A 2019-09-26 2019-09-26 Sandwich method antibody detection method and test paper Pending CN110672840A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910921771.7A CN110672840A (en) 2019-09-26 2019-09-26 Sandwich method antibody detection method and test paper

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910921771.7A CN110672840A (en) 2019-09-26 2019-09-26 Sandwich method antibody detection method and test paper

Publications (1)

Publication Number Publication Date
CN110672840A true CN110672840A (en) 2020-01-10

Family

ID=69079637

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910921771.7A Pending CN110672840A (en) 2019-09-26 2019-09-26 Sandwich method antibody detection method and test paper

Country Status (1)

Country Link
CN (1) CN110672840A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010011775A2 (en) * 2008-07-23 2010-01-28 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Detection and quantification of antigens
CN206618762U (en) * 2017-03-30 2017-11-07 厦门依柯利斯医疗科技有限公司 N-terminal plasma pro-brain natriuretic peptide levels immunochromatographiassay assay quantitative detection test paper in a kind of people's whole blood
CN107328938A (en) * 2016-09-23 2017-11-07 清华大学深圳研究生院 Propepsin and helicobacter pylori antibody detection method and its kit
CN207036863U (en) * 2017-03-30 2018-02-23 厦门依柯利斯医疗科技有限公司 Brain natriuretic peptide immunochromatography quantification kit in a kind of people's whole blood
US20190219569A1 (en) * 2016-12-30 2019-07-18 Wuhan Newcando Biotechnology Co., Ltd. Fluorescence immunochromatographic detection card and a preparation method therefor and use thereof
CN110261597A (en) * 2019-06-06 2019-09-20 三诺生物传感股份有限公司 A kind of IA-2 autoantibody detection strip

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010011775A2 (en) * 2008-07-23 2010-01-28 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Detection and quantification of antigens
CN107328938A (en) * 2016-09-23 2017-11-07 清华大学深圳研究生院 Propepsin and helicobacter pylori antibody detection method and its kit
US20190219569A1 (en) * 2016-12-30 2019-07-18 Wuhan Newcando Biotechnology Co., Ltd. Fluorescence immunochromatographic detection card and a preparation method therefor and use thereof
CN206618762U (en) * 2017-03-30 2017-11-07 厦门依柯利斯医疗科技有限公司 N-terminal plasma pro-brain natriuretic peptide levels immunochromatographiassay assay quantitative detection test paper in a kind of people's whole blood
CN207036863U (en) * 2017-03-30 2018-02-23 厦门依柯利斯医疗科技有限公司 Brain natriuretic peptide immunochromatography quantification kit in a kind of people's whole blood
CN110261597A (en) * 2019-06-06 2019-09-20 三诺生物传感股份有限公司 A kind of IA-2 autoantibody detection strip

Similar Documents

Publication Publication Date Title
CN111413501A (en) Application of detection test strip in preparation of kit for detecting THSD7A antibody
JPS5949545B2 (en) Antibody, antigen or antibody: reagent for antigen complex analysis
JPH01150857A (en) Latex agglutination immunoassay with presence of hemoglobin
JPH05508013A (en) Measurement method using internal calibration to determine the amount of analyte in a sample
EP3514543B1 (en) Quantitative controls and calibrators for cellular analytes
Cheubong et al. Molecularly imprinted nanogels capable of porcine serum albumin detection in raw meat extract for halal food control
CA2588230A1 (en) Immunoassay employing two-step internal calibration reaction
JP5767362B1 (en) Immunochromatography analyzer, immunochromatography analysis method, and immunochromatography analysis kit
WO2013116847A1 (en) Extraction of mycotoxins
CN106370861A (en) C reactive protein saliva test paper strip and preparation method thereof
CN107407665A (en) For detecting the sample modulation kit of monoclonal antibody
CN109459570A (en) The colloid gold immune test paper preparation method of lead ion in a kind of quick detection blood of human body
CN101046479B (en) Process of preparing human serum base matter containing no target protein
CA2656133A1 (en) A method and device for processing a biological fluid for analyte determination
KR101628221B1 (en) Test reagent, and method for measuring analyte in test sample using same
CN110672840A (en) Sandwich method antibody detection method and test paper
CN110824157B (en) Method for quickly separating red blood cells for immunochromatography detection kit
CN110672841A (en) Sandwich method antigen detection method and test paper
CN108918479A (en) Time-resolved fluoroimmunoassay chromatograph test strip of quantitative detection interleukin-6 and preparation method thereof
Zhou et al. Determination of alkaline phosphatase activity and of carcinoembryonic antigen by using a multicolor liquid crystal biosensor based on the controlled growth of silver nanoparticles
CN110672842A (en) Competitive antigen detection method and test paper
JPS58211662A (en) Uniform system combination analysis method for measuring sample in test sample and reagent system used for said method
JP2009192222A (en) Immunoassay method
Shen et al. Detection of antisperm antibody in human serum using a piezoelectric immunosensor based on mixed self-assembled monolayers
CN116930489A (en) Chromatographic test strip, detection kit and method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200110

WD01 Invention patent application deemed withdrawn after publication